title: The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.
abstract: The kinetics of T and B cell immune recovery after bone marrow transplantation (BMT) is affected by many pre- and post-transplant factors. Because of the profoundly depleted baseline T and B cell immunity in recombination activating gene 2 (RAG-2)-deficient severe combined immunodeficiency (SCID) patients, some of these factors are eliminated, and the immune recovery after BMT can then be clearly assessed. This process was followed in ten SCID patients in parallel to their associated transplant-related complications. Early peripheral presence of T and B cells was observed in 8 and 4 patients, respectively. The latter correlated with pre-transplant conditioning therapy. Cells from these patients carried mainly signal joint DNA episomes, indicative of newly derived B and T cells. They were present before the normalization of the T cell receptor (TCR) and the B cell receptor (BCR) repertoire. Early presentation of the ordered TCR gene rearrangements after BMT occurred simultaneously, but this pattern was heterogeneous over time, suggesting different and individual thymic recovery processes. Our findings early after transplant could suggest the long-term patients' clinical outcome. Early peripheral presence of newly produced B and T lymphocytes from their production and maturation sites after BMT suggests donor stem cell origin rather than peripheral expansion, and is indicative of successful outcome. Peripheral detection of TCR excision circles and kappa-deleting recombination excision circles in RAG-2-deficient SCID post-BMT are early markers of T and B cell reconstitution, and can be used to monitor outcome and tailor specific therapy for patients undergoing BMT.
authors.affiliation: Cancer Research Center, Tel Hashomer, Israel.
authors.forename: Atar
authors.initials: A
authors.lastname: Lev
authors.forename: Amos J
authors.initials: AJ
authors.lastname: Simon
authors.forename: Mor
authors.initials: M
authors.lastname: Bareket
authors.forename: Bella
authors.initials: B
authors.lastname: Bielorai
authors.forename: Daphna
authors.initials: D
authors.lastname: Hutt
authors.forename: Ninette
authors.initials: N
authors.lastname: Amariglio
authors.forename: Gideon
authors.initials: G
authors.lastname: Rechavi
authors.forename: Raz
authors.initials: R
authors.lastname: Somech
mesh_terms: D001402:B-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D004268:DNA-Binding Proteins / Q000172:deficiency*; D005260:Female; D015322:Gene Rearrangement, B-Lymphocyte; D015329:Gene Rearrangement, T-Lymphocyte; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D007223:Infant; D007700:Kinetics; D008297:Male; D011948:Receptors, Antigen, T-Cell / Q000235:genetics; D011995:Recombination, Genetic / Q000276:immunology; D016511:Severe Combined Immunodeficiency / Q000235:genetics / Q000276:immunology* / Q000378:metabolism / Q000601:surgery*; D016019:Survival Analysis; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism
chemical_list: D004268:DNA-Binding Proteins; D011948:Receptors, Antigen, T-Cell; C064655:V(D)J recombination activating protein 2